Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
20.00
-0.55 (-2.68%)
At close: Dec 5, 2025, 4:00 PM EST
19.02
-0.98 (-4.90%)
After-hours: Dec 5, 2025, 6:09 PM EST

Burning Rock Biotech Revenue

Burning Rock Biotech had revenue of 131.62M CNY in the quarter ending September 30, 2025, with 2.31% growth. This brings the company's revenue in the last twelve months to 539.28M, up 5.56% year-over-year. In the year 2024, Burning Rock Biotech had annual revenue of 515.82M, down -4.02%.

Revenue (ttm)
539.28M CNY
Revenue Growth
+5.56%
P/S Ratio
2.81
Revenue / Employee
800,111 CNY
Employees
674
Market Cap
215.33M USD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024515.82M-21.61M-4.02%
Dec 31, 2023537.44M-25.80M-4.58%
Dec 31, 2022563.24M55.38M10.90%
Dec 31, 2021507.86M77.96M18.13%
Dec 31, 2020429.90M48.23M12.64%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings